Cancer · June 26, 2026
FDA Approves New Pill That Destroys Estrogen Receptors in Resistant Breast Cancer
Veppanu (vepdegestrant) receives FDA approval, offering breast cancer patients a new hormonal treatment option....
Treatment · May 1, 2026
FDA Approves First Pill That Degrades Cancer Proteins in Breast Cancer Advance
FDA approves VEPPANU as an innovative new treatment option for patients....